Author: Elion Medical Communications

Industry Insights: MedComms 15 January

Industry Insights MedComms

In this piece, we highlight two topics in the medical publishing industry that are sparking discussions. This piece focuses on disinformation and misinformation, as these have been discussed as being some of the top risks in medical writing in 2024. The Food and Drug Administration (FDA) commissioner has urged the clinical community to redouble efforts […]

Industry Insights: Healthcare 18 December

Industry Insight: Healthcare

We have summarised three articles to help keep you informed of the latest developments in the industry. This week our Industry Insights focus on a major breakthrough for severe asthma treatment, three-year follow-up data from the phase 2b randomised KEYNOTE-942-/mRNA-4157-P201 study, and a new clinical trial looking at stem cell-based treatment for blood glucose control […]

Industry Insights: AI 14 December

Industry Insight: AI

This Industry Insights: AI focuses on the use of AI in academic writing, ranging from writing summaries and providing feedback to conducting research and writing a paper. Researchers from Stanford have created an automated pipeline using GPT-4 to provide comments on scientific papersthat were quantitatively compared with human peer-reviewed feedback. The overlap in points raised […]

Industry Insights: MedComms 7 December

Industry Insights MedComms

In this piece, we highlight three topics in the medical publishing industry that are sparking discussions. We consider the ethical use of AI in medical publishing, followed by recommendations for using AI in scholarly communication. We also explore the involvement of patients as stakeholders in medical research. As the world embraces the advancing role of […]

Industry Insights: Healthcare 28 November

Industry Insight: Healthcare

We have summarised three articles to help keep you informed of the latest developments in the industry. This week our Industry Insights look at the U.S Food and Drug Administration (FDA) approval of Zepbound (tirzepatide) for chronic weight management, a World Health Organisation (WHO) statement on reported clusters of respiratory illness in children in northern […]

Industry Insights: AI 23 November

Industry Insight: AI

This artificial intelligence (AI) Industry Insight focuses on the latest updates on the use of AI in the industry, from its use amongst postdoctoral researchers to how it is being used to create plain language summaries. We also discuss the ‘Science’ family of journals’ new editorial policies on image and text integrity. Nature polled researchers […]

Industry Insights: MedComms 13 November

Industry Insights MedComms

Here we highlight three topics in publishing currently sparking discussions within the industry. We explore issues related to non-native English speakers in science, delve into the debate of using AI or knowledge experts in medical writing, and discuss the impact altmetrics (Alternative Metrics) might have on addressing the gender bias that disadvantages women in STEM. […]

Industry Insights: Healthcare 6 November

Industry Insight: Healthcare

This week our Industry Insights: Healthcare looks at the potential for Food and Drug Administration (FDA) approval of CRISPR for sickle cell anaemia, new lung cancer screening guidelines by the American Cancer Society, and FDA approval for Phathom’s Voquezna. A panel of external advisors to the FDA has found the safety data for Exagamglogene Autotemcel […]

Industry Insights: AI 3 November

Industry Insight: AI

This artificial intelligence (AI) Industry Insights focuses on the latest position statements on the use of in MedComms from leading professional organisations:  the International Society for Medical Publication Professionals (ISMPP), the Healthcare Communications Association (HCA), and the Medical Affairs Professional Society (MAPS). The International Society for Medical Publication Professionals (ISMPP) has released a position statement […]

Industry Insights: MedComms 24 October

Industry Insights MedComms

In this piece, we spotlight three issues in the publishing world that are driving conversations within the industry. We look at inaccurate author disclosures in medical publishing, delve into the open access debate, and discuss the art of crafting suitable lay titles for clinical trials. The problem of unreliable author disclosures persists in the medical […]

Industry Insights: AI 12 October

Industry Insight: AI

This Insight focuses on: 1) the Healthcare Communication Association’s position paper on AI, 2) six principles that can help you start using AI for communications, and 3) the value of the AI market in medical writing. The Healthcare Communications Association (HCA) has published a position paper on AI in Current Medical Research and Opinion. The […]